Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: Results from the CLEAR HPV study

American Journal of Clinical Pathology

Volumn 143, Issue 2, 2015, Pages 160-167

  Castle, Phillip E ^a   Cuzick, Jack ^b   Stoler, Mark H ^c   Wright, Thomas C ^d   Reid, Jennifer L ^e   Dockter, Janel ^e   Giachetti, Cristina ^e   Getman, Damon ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Columbia University School of Medicine ^*  (United States)

^e Hologic   (United States)

Author keywords

Aptima; ASC US; Cervical cancer; Cervical intraepithelial neoplasia; E6 E7 mRNA; Genotyping; HPV

Indexed keywords

ADENOCARCINOMA IN SITU; ADULT; AGED; ARTICLE; CANCER RISK; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR; VALIDATION STUDY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

VIRUS RNA;

ADULT; AGED; AGED, 80 AND OVER; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84925283795     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPLCD8TTOMLJTB     Document Type: Article

References (16)

1. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-172.
2. Massad LS, Einstein MH, Huh WK, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1-S27.
3. US Food and Drug Administration. APTIMA HPV assay-P100042. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm278520.htm. Accessed December 12, 2014.
4. Stoler M, Wright T, Cuzick J, et al. APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results. AJOG. 2013;208:144-148.
5. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
6. Wright TC, Ronnett BM, Kurman RJ, et al. Precancerous lesions of the cervix. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York, NY: Springer; 2011:193-252.
7. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.
8. Castle PE, Solomon D, Schiffman M, et al. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst. 2005;20;97:1066-1071.
9. Schiffman M, Adrianza ME; ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 2000;44:726-742.
10. Kurman RJ, Henson DE, Herbst AL, et al. Interim guidelines for management of abnormal cervical cytology: the 1992 National Cancer Institute Workshop. JAMA. 1994;271:1866-1869.
11. Stoler MH, Wright TC Jr, Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468-475.
12. De Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-1056.
13. Guan P, Howell-Jones R, Li N, et al. Human papillomavirus types in 115, 789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349-2359.
14. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and metaanalysis. Lancet. 2006;367:489-498.
15. Castanon A, Brocklehurst P, Evans H, et al. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study. BMJ. 2012;345:e5174.
16. De Sanjose S, Wheeler CM, Quint WG, et al. Age-specific occurrence of HPV16- and HPV-18 related cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:1313-1318.